NCT05896839 2026-03-19Immunotherapy in Combination With Prednisone and Sirolimus for Kidney Transplant Recipients With Unresectable or Metastatic Skin CancerNational Cancer Institute (NCI)Phase 1/2 Recruiting16 enrolled
NCT02834013 2026-03-18Nivolumab and Ipilimumab in Treating Patients With Rare TumorsNational Cancer Institute (NCI)Phase 2 Active not recruiting818 enrolled